PG vs UPB · P/E 25, rev $84.28B vs rev $2.4M
Procter & Gamble Company (PG) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. UPB currently screens at market cap $407.3M.
Not investment advice. Open the PG and UPB stock pages for the full models.
Not investment advice.